InsidersTradesSigma
Track the IPCA Laboratories Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares are listed on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, IPCA Laboratories Limited has recorded 16 reports. Market capitalisation: €440bn. The latest transaction was reported on 17 February 2026 (Sale). Among the most active insiders: Paschim Chemicals Private Limited. The full history is free.
16
Insider Decl.
n/a
Thresholds
€459,850
4 ops.
Buy Volume
€68m
12 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,656 of 29,063 companies
58.2
score / 100
Value38
Quality78
FCF yld1.1%
Earn yld2.6%
EV/EBITDA21.7x
ROE13%
Gross mgn69%
Net mgn12%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 February 2026
Declarations16 total
3,000 shares@ ₹1,482.2183100.0% of flowEquity SharesSEBI:99c1fa2a3cf0b7341a1f73b84dc84afeebc1f680
2,220 shares@ ₹1,413.0216100.0% of flowEquity SharesSEBI:63e5184524765d41c31682fe6123987a95af9949
10,187,058 sharesEquity SharesSEBI:ea08648d3ac5da43ea1e3a4796a926d68d06cda6
10,173,000 sharesEquity SharesSEBI:52505fe2908d88b3e8d9c4c68b21b861f7f7507c
14,058 sharesEquity SharesSEBI:750da4256c5f6e0a644f76f10b6b1a444a8c9bfa
4,000,000 shares@ ₹1,499.2458100.0% of flowEquity SharesSEBI:94f0b4a72c1b33668e85acd3c2cd325163b016ba
35,000 shares@ ₹1,200.9654100.0% of flowEquity SharesSEBI:9b880dfd82a0c6a948d5497f3954a740cdce8f76
20,000 shares@ ₹1,081.8467100.0% of flowEquity SharesSEBI:5354172f0889784fc8727cab693fcce0cdbb5502
4,000,000 sharesEquity SharesSEBI:e1a134883d16b81a955ba52910acc269eead952c
302,000 sharesEquity SharesSEBI:798058b83ec55a85199f0dc14eed461e64ada5d3
20,000 shares@ ₹1,026.816846.8% of flowEquity SharesSEBI:c28f7e729b5d591e6c4dbf188f09106e3c73d046
450 shares@ ₹2,441.15780.0000% mcap100.0% of flowEquity SharesSEBI:b862456a1a39501f1a37fd82251b03d209e8f714
4,000 shares@ ₹2,510.000.0000% mcap100.0% of flowEquity SharesSEBI:cff1f76106c4923f0f9431cd38dd99a7bca9cf6a
10,000 shares@ ₹2,421.89790.0001% mcap100.0% of flowEquity SharesSEBI:4059a27a241926da5e5a0a5d531d4575ab345076
1,597 shares@ ₹2,383.30240.0000% mcap100.0% of flowEquity SharesSEBI:657f288567c9ecc5b4b94334f2c2e01982d91b1c
16 of 16 declarations
关于 IPCA Laboratories Limited
IPCA Laboratories Limited 是一家印度制药公司，从事仿制药和医药产品的制造。该公司在孟买证券交易所上市，股票代码为XBOM。